Exploring treatment with Ribociclib alone or in sequence/combination with Everolimus in ER+HER2−Rb wild-type and knock-down in breast cancer cell lines

Table 1 Sequential or concurrent dosing schedule in Rb WT and KD MCF-7 cells

A) Sequential dosing schedule
	3 days	2 days
1	Ribociclib	Vehicle
2	Ribociclib	Everolimus
3	Everolimus	Vehicle
4	Everolimus	Ribociclib
B) Concurrent dosing schedule
	3 days
1	Ribociclib + Everolimus
2	Ribociclib + Vehicle
3	Everolimus + Vehicle

A) Sequential dosing schedule of combination of Rib and Eve; B) Concurrent dosing schedule of combination of Rib and Eve

ISSN: 1471-2407